CAPTAIN STUDY: EFFECTS OF FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL ON FEV1 IMPROVEMENT IN ASTHMA ACCORDING TO AGE

被引：0
|
作者：
Hanania, N.
Bailes, Z.
Barnes, N.
Gardiner, F.
Lugogo, N.
Mannino, D.
Mehta, V.
Nyanjom, D.
Sitz, K.
Kerstjens, H.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2020年 / 125卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P206
引用
收藏
页码：S28 / S28
页数：1
相关论文
共 50 条
  • [1] CAPTAIN STUDY: TREATMENT OUTCOMES FROM FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL ACCORDING TO HISTORY OF SEVERE ASTHMA EXACERBATIONS
    Oppenheimer, J.
    Brusselle, G.
    Busse, W.
    Fowler, A.
    Jain, N.
    Mannino, D.
    Pavord, I.
    Win, P.
    Zarankaite, A.
    Kerwin, E.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S26 - S27
  • [2] Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN study
    Nakamura, Yoichi
    Hozawa, Soichiro
    Sagara, Hironori
    Ohbayashi, Hiroyuki
    Lee, Laurie A.
    Crawford, Jodie
    Tamaoki, Jun
    Nishi, Takanobu
    Fowler, Andrew
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (09) : 1657 - 1665
  • [3] The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: A Pre-Specified Analysis of Safety According to Age
    Criner, G. J.
    Dransfield, M.
    Halpin, D. M. G.
    Han, M. K.
    Jones, C. E.
    Kilbride, S.
    Lange, P.
    Lomas, D. A.
    Martinez, F.
    Pascoe, S.
    Singh, D.
    Wise, R.
    Lipson, D. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [4] The IMPACT Trial: Single Inhaler Triple Therapy fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: Analysis According to Smoking Status
    Halpin, D. M. G.
    Bardsley, S.
    Criner, G.
    Dransfield, M.
    Han, M. K.
    Jones, C. E.
    Kilbride, S.
    Lomas, D. A.
    Martinez, F.
    Pascoe, S.
    Singh, D.
    Wise, R.
    Lipson, D. A.
    Lange, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [5] Population Pharmacokinetic Modeling of Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol in Patients with Asthma, Using Data from a Phase IIIA Study (CAPTAIN)
    Yang, Shuying
    Lee, Laurie A.
    Sule, Neal
    Fowler, Andrew
    Peachey, Guy
    CLINICAL PHARMACOKINETICS, 2021, 60 (07) : 887 - 896
  • [6] Population Pharmacokinetic Modeling of Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol in Patients with Asthma, Using Data from a Phase IIIA Study (CAPTAIN)
    Shuying Yang
    Laurie A. Lee
    Neal Sule
    Andrew Fowler
    Guy Peachey
    Clinical Pharmacokinetics, 2021, 60 : 887 - 896
  • [7] Captain Study: Evaluating the Efficacy of Once-Daily, Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Versus FF/VI in Inadequately Controlled Asthma Using Change in Asthma Control Questionnaire and the Relationship with Trough FEV1
    Fowler, A.
    Kerstjens, H.
    Bailes, Z.
    Tabberer, M.
    Barnes, N.
    Peachey, G.
    Oppenheimer, J.
    Lee, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [8] Fluticasone Furoate, Alone Or In Combination With Vilanterol, Decreases The Rate Of Fev1 Decline In Patients With Moderate Airflow Obstruction: Summit Study
    Celli, B. R.
    Martinez, F. J.
    Anderson, J.
    Brook, R.
    Crim, C.
    Kilbride, S.
    Newby, D. E.
    Vestbo, J.
    Yates, J.
    Calverley, P. M. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [9] Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study
    Bremner, Peter R.
    Birk, Ruby
    Brealey, Noushin
    Ismaila, Afisi S.
    Zhu, Chang-Qing
    Lipson, David A.
    RESPIRATORY RESEARCH, 2018, 19
  • [10] Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study
    Peter R. Bremner
    Ruby Birk
    Noushin Brealey
    Afisi S. Ismaila
    Chang-Qing Zhu
    David A. Lipson
    Respiratory Research, 19
12345